WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004007742) CHROMOSOME 6 AND 9 GENES INVOLVED IN PREMATURE CANITIES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/007742    International Application No.:    PCT/FR2003/002154
Publication Date: 22.01.2004 International Filing Date: 09.07.2003
IPC:
A61K 48/00 (2006.01), A61Q 5/10 (2006.01), C12Q 1/68 (2006.01)
Applicants: L'OREAL [FR/FR]; 14, rue Royal, F-75008 Paris (FR) (For All Designated States Except US).
DE LACHARRIERE, Olivier [FR/FR]; (FR) (For US Only).
BLOUIN, Jean-Louis [FR/FR]; (FR) (For US Only).
DELOCHE, Claire [FR/FR]; (FR) (For US Only).
ANTONARAKIS, Stylianos [GR/CH]; (CH) (For US Only)
Inventors: DE LACHARRIERE, Olivier; (FR).
BLOUIN, Jean-Louis; (FR).
DELOCHE, Claire; (FR).
ANTONARAKIS, Stylianos; (CH)
Agent: ERNEST GUTMANN - YVES PLASSERAUD S.A.; 3, rue Chauveau-Lagarde, F-75008 Paris (FR)
Priority Data:
02/08696 10.07.2002 FR
03/04360 08.04.2003 FR
Title (EN) CHROMOSOME 6 AND 9 GENES INVOLVED IN PREMATURE CANITIES
(FR) GENES DES CHROMOSOMES 6 ET 9 IMPLIQUES DANS LA CANITIE PRECOCE
Abstract: front page image
(EN)The invention concerns the use of at least one polynucleotide fragment comprising 18 consecutive nucleotides whereof the sequence corresponds to all or part of a human chromosome 6 gene selected among the HLAG, NT__007592.445, NT_007592.446, NT_007592.506, NT_007592.507, NT_007592.508, HSPAIB, G8, NEU1, NG22, BAT8, HLA-DMB, HLA-DMA, BRD2, HLA-DQA1, HLA-DQA2, NT_007592.588, GRM4, RNF23, FLJ22638, NT_007592.459 and NT_007592.457 genes, or whereof the sequence corresponds to all or part of the human chromosome 9 gene selected among the FREQ, NT_030046.18, NT_030046.17, GTF3C5, CEL, CELL, FS, ABO, BARHL1, DDX31, GTF3C4 and Q96MA6 genes, the use of agents capable of modifying the function attached to one of said genes, the use of expression products of one of said genes and use of agents capable of modifying the function of said expression products, for cosmetic, therapeutic or diagnostic applications.
(FR)Utilisation d'au moins un fragment polynucléotidique comprenant au moins 18 nucléotides consécutifs dont la séquence correspond à tout ou partie d'un gène du chromosome 6 humain choisi parmi les gènes HLAG, NT__007592.445, NT_007592.446, NT_007592.506, NT_007592.507, NT_007592.508, HSPAIB, G8, NEU1, NG22, BAT8, HLA-DMB, HLA-DMA, BRD2, HLA-DQA1, HLA-DQA2, NT_007592.588, GRM4, RNF23, FLJ22638, NT_007592.459 et NT_007592.457, ou dont la séquence correspond à tout ou partie d'un gène du chromosome 9 humain choisi parmi les gènes FREQ, NT_030046.18, NT_030046.17, GTF3C5, CEL, CELL, FS, ABO, BARHL1, DDX31, GTF3C4 et Q96MA6, utilisation d'agents capables de modifier la fonction attachée à l'un de ces gènes, utilisation des produits d'expression de l'un de ces gènes et utilisation d'agents capables de modifier la fonction de ces produits d'expression, à des fins cosmétiques, thérapeutiques ou diagnostiques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: French (FR)
Filing Language: French (FR)